As J&J Faces Crisis, Questions Arise About Board’s Role
This has been a year to forget for Johnson & Johnson (NYSE: JNJ). Unfortunately for shareholders, the company’s board appears ill-equipped to handle two serious problems that may tarnish the company’s reputation.…